Clinical Research Detail Title Of Study A Phase III, randomized, double-blind, placebo-controlled, multi-center clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS Disease Condition Multiple Sclerosis Phase of Trial Phase-3 Discipline Neurology Start date of Trial 4/29/2009 Closing Date of Trial 4/29/2013 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]